Midwest CV Forum Rates Increase Oct. 18 – Register Today!

The Midwest Cardiovascular Forum is a 1.5-day conference exploring the latest in cardiology. Sessions include topics for seasoned cardiologists, fellows-in-training, and cardiovascular team members. The 2023 Forum will take place on November 4-5 at the Minneapolis Convention Center in Minneapolis, Minnesota.

Registration rates increase after Wednesday, October 18. Register today to save!

Midwest CV Forum Poster Contest Abstracts Due Oct. 17

Midwest CV Forum Posters

Fellows in Training, residents and medical students are invited to participate in the 2023 Midwest Cardiovascular Forum Poster Contest. There will be an award for first, second, and third place in each category. Presenters will be judged on the following criteria: originality, scientific content, presentation and answer to questions raised by the case. Winners will be announced on-site at the 2023 Midwest Cardiovascular Forum.

Contest Eligibility:

  • There are Fellow, Resident, and Medical Student categories in this contest.
  • There are two types of entries: Case Studies and Research.
  • The research or work submitted must be recent. June 2021-September 2023 is the timeframe for consideration of poster work.
  • Conference registration is free to those who have a poster accepted in the competition.

Live Interactive CME Webcast: Homozygous Hypercholesterolemia

Join Us for a Live Interactive CME Webcast!

“Cross-Setting Strategies for Improved Identification, Diagnosis, and Management of Homozygous Hypercholesterolemia” will take place virtually on Wednesday, October 25, 2023 at 6:00 PM CT.

This webcast was organized for the ACC Great Plains, Iowa and Minnesota Chapters.

Program Overview

Homozygous familial hypercholesterolemia (HoFH) is a genetic disorder characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to premature cardiovascular disease. Affected individuals are typically less responsive or unresponsive to standard lipid-lowering therapies (ie, statins and PCSK9 inhibitors) and may benefit from treatments with alternative mechanisms of action, such as the recently FDA-approved ANGPTL3 inhibitor evinacumab. With this in mind, this program has been designed to educate clinicians about the prevalence of HoFH, the importance of HoFH screening, and the benefits and limitations of current therapies for lipid management in patients with the disease. The nationally recognized expert faculty will also provide practical advice to attendees, based on their personal success, regarding strategies that improve patient access to newer lipid-lowering therapies.

Target Audience

This educational activity has been designed for US cardiologists and internal medicine physicians, nurse practitioners, and physician assistants involved in the identification, diagnosis, and management of patients with HoFH.

Credit Designation

Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM.

Faculty Presenter

Mary McGowan, MD
Assistant Professor of Medicine
Geisel School of Medicine at Dartmouth
Lipid Clinic & Lipid Research
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Register Now: Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Disease Overview, Image Findings, and Case Study

Register now for this upcoming two-part webinar series.

Learning Objectives:

  1. Review cardiac amyloidosis and its pathogenesis, subtypes, prevalence and the importance of identification of ATTR-CM.
  2. Identify signs, symptoms and modalities used for screening for ATTR-CM in everyday practice.
  3. Discuss the Multi-Societal Expert Consensus Recommendations (MECR) on imaging cardiac amyloidosis and describe the role of echocardiography, cardiovascular magnetic resonance (CMR) and nuclear scintigraphy in diagnosing and typing of patients with suspected or known cardiac amyloidosis.
  4. Review and discuss a patient case study.

Speaker:

Tamara S. Evans, BS, Pharm.D., MPH, PAHM
Senior Medical Director, Pfizer Inc
US Medical Affairs, Rare Cardiology

Register Now: 2023 FIT Echo Bootcamp

Registration is now open for our fourth annual FIT Echo Bootcamp! Join other Fellows in Training for an in-depth study on Echocardiographic Examinations and Emergencies. This four-part virtual series is led by Dr. Richard H. Marcus of the Iowa Heart Center.

Dr. Rick Marcus is one of the nation’s leading experts in the use of echocardiography to diagnose heart disease. Read more.

Bootcamp Dates:

  • July 10
  • July 12
  • July 17
  • July 19

Save the Date: 2023 FIT Echo Bootcamp

Join other Fellows in Training for an in-depth study on Echocardiographic Examinations and Emergencies. This four-part virtual series is led by Dr. Rick Marcus of the Iowa Heart Center.

Dr. Richard Marcus is one of the nation’s leading experts in the use of echocardiography to diagnose heart disease. Read more.

Bootcamp Dates:

  • July 10
  • July 12
  • July 17
  • July 19

More information coming soon.

ACC.24 Scientific Session & Expo

The American College of Cardiology’s 73rd Annual Scientific Session & Expo ACC.24 is coming up on April 6 – 8, 2024 in Atlanta, GA.

At ACC.24 you’ll have the opportunity to reconnect with your colleagues from around the world, explore the latest science and innovation, and gain valuable insights into practice-changing updates in care. Here you’ll get everything you need to transform cardiovascular care for all!

Can’t make it to Atlanta? Join us virtually for the top late-breaking clinical trials.

Read more.

1 2 3 4